Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1591 to 1605 of 2183 results for guidelines

  1. Physical activity and the environment (PH8)

    This guideline has been updated and replaced by NICE guideline NG90.

    Withdrawn guideline

  2. Asthma: diagnosis, monitoring and chronic asthma management (NG80)

    This guideline has been updated and replaced by NICE guideline NG245.

    Withdrawn guideline

  3. Needle and syringe programmes (PH18)

    This guideline has been updated and replaced by NICE guideline PH52.

    Withdrawn guideline

  4. Workplace health: long-term sickness absence and incapacity to work (PH19)

    This guideline has been updated and replaced by NICE guideline NG146.

    Withdrawn guideline

  5. Mental wellbeing at work (PH22)

    This guideline has been updated and replaced by NICE guideline NG212.

    Withdrawn guideline

  6. Maternal and child nutrition (PH11)

    This guideline has been updated and replaced by NICE guideline NG247.

    Withdrawn guideline

  7. HIV testing: increasing uptake in men who have sex with men (PH34)

    This guideline has been updated and replaced by NICE guideline NG60.

    Withdrawn guideline

  8. Tuberculosis: identification and management in under-served groups (PH37)

    This guideline has been updated and replaced by NICE guideline NG33.

    Withdrawn guideline

  9. Early and locally advanced breast cancer: diagnosis and treatment (CG80)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guideline

  10. Unstable angina and NSTEMI: early management (CG94)

    This guideline has been updated and replaced by NICE guideline NG185.

    Withdrawn guideline

  11. Bivalirudin for the treatment of ST-segment-elevation myocardial infarction (TA230)

    This guideline has been updated and replaced by NICE guideline NG185.

    Withdrawn guidance

  12. Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer (TA112)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guidance

  13. Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer (TA107)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guidance

  14. Paclitaxel for the adjuvant treatment of early node-positive breast cancer (TA108)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guidance

  15. Docetaxel for the adjuvant treatment of early node-positive breast cancer (TA109)

    This guideline has been updated and replaced by NICE guideline NG101.

    Withdrawn guidance